Late-term Abortions Between 14 and 16 Weeks of Gestation: Comparison of Hemorrhagic Risks in Surgical vs. Medical Abortions
IVG-Tardives
1 other identifier
observational
50
1 country
1
Brief Summary
Since the extension of the legal abortion limit to 16 weeks by the law of March 2, 2022, we must adapt our care to reduce the risks associated with this procedure. According to the French National Authority for Health (HAS), all abortions after 9 weeks of gestation should be performed surgically, but the French National College of Gynecologists and Obstetricians (CNGOF) indicates that each patient should have the choice of method regardless of the gestational age at the time of the abortion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 19, 2025
CompletedFirst Submitted
Initial submission to the registry
January 2, 2026
CompletedFirst Posted
Study publicly available on registry
January 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 19, 2026
January 13, 2026
January 1, 2026
1 year
January 2, 2026
January 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bleeding (in cc)
Bleeding \> 500 cc means a very large blood loss
During surgery
Eligibility Criteria
\- Adult woman with single or multiple pregnancy and undergoing an abortion between 14 and 16 weeks of gestation at the Strasbourg University Hospital between March 2, 2022, and March 2, 2026
You may qualify if:
- Adult woman
- Single or multiple pregnancy
- Undergoing an abortion between 14 and 16 weeks of gestation at the Strasbourg University Hospital between March 2, 2022, and March 2, 2026
You may not qualify if:
- Missed Pregnancy
- Term \< 14 Weeks of Gestation or \> 16 Weeks of Gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Gynécologie-Obstétrique - CHU de Strasbourg - France
Strasbourg, 67091, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2026
First Posted
January 13, 2026
Study Start
May 19, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 19, 2026
Last Updated
January 13, 2026
Record last verified: 2026-01